• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Alterity Therapeutics(ATHE.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Nov10
Alterity Therapeutics Presents Favorable Data on ATH434 for Orthostatic Hypotension and MSA
12:26
Oct14
Jason McCarthy Issues Buy Rating on Alterity Therapeutics Stock
18:56
Sep29
Alterity Therapeutics Predicts ATH434 Global Peak Sales of $2.4 Billion
05:01
Aug29
Alterity Therapeutics released FY2025 earnings on August 28 (EST), actual revenue USD 3.526 M (forecast USD 3.591 M), actual EPS USD -0.7386 (forecast USD -0.82)
03:00
Alterity Therapeutics released FY2025 9 Months Earnings on August 28 (EST), actual revenue USD 2.259 M, actual EPS USD -0.6765
03:00
Alterity Therapeutics released FY2025 Q3 earnings on August 28 (EST), with actual revenue of USD 1.205 M and EPS of USD -0.1252
03:00

Schedules & Filings

Schedules
Filings
Aug28
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 1.25 M, Net Income -1.623 M, EPS -0.1299

Feb28
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 499.51 K, Net Income -2.231 M, EPS -0.2612

Aug29
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 706.56 K, Net Income -4.208 M, EPS -0.5262

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
LVRO
1.362
+202.67%
+0.915
BNAI
4.010
+72.84%
+1.680
GPUS
0.2753
+49.95%
+0.092
PRZO
1.220
+49.69%
+0.405
TBMCR
0.3400
+40.15%
+0.097
NTCL
0.4840
+40.09%
+0.139
TXXD
17.969
+39.16%
+5.057
DVLT
0.8957
+37.36%
+0.245
CHOW
0.8298
+36.46%
+0.222
UAVS
1.110
+36.40%
+0.306
View More